Comparison of two rapid assays for Clostridium difficile common antigen and a C difficile toxin A/B assay with the cell culture neutralization assay

American Journal of Clinical Pathology

Volumn 133, Issue 1, 2010, Pages 107-109

  Reller, Megan E ^a   Alcabasa, Romina C ^a   Lema, Clara A ^a   Carroll, Karen C ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

Clostridium difficile; Clostridium infections; Cytotoxins; Isolation and purification

Indexed keywords

VIRUS ANTIBODY;

ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; HEPATITIS B VIRUS; HUMAN; INTERMETHOD COMPARISON; NONHUMAN; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; VIRUS CORE; VIRUS DETECTION;

ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BACTERIAL TOXINS; BACTERIOLOGICAL TECHNIQUES; CELLS, CULTURED; CLOSTRIDIUM DIFFICILE; ENTEROTOXINS; FECES; FIBROBLASTS; FORESKIN; GLUTAMATE DEHYDROGENASE; HUMANS; MALE; NEUTRALIZATION TESTS; PREDICTIVE VALUE OF TESTS;

EID: 73949135042     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/AJCPO3QWOU8CYGEU     Document Type: Article

References (11)

1. Bartlett JG. Narrative review: the new epidemic of Clostridium difficile-associated enteric disease. Ann Intern Med. 2006;145:758-764.
2. Lee SD, Turgeon DK, Ko CW, et al. Clinical correlation of toxin and common antigen enzyme immunoassay testing in patients with Clostridium difficile disease. Am J Gastroenterol. 2003;98:1569-1572.
3. Aldeen WE, Bingham M, Aiderzada A, et al. Comparison of the TOX A/B test to a cell culture cytotoxicity assay for the detection of Clostridium difficile in stools. Diagn Microbiol Infect Dis. 2000;36:211-213.
4. Ticehurst JR, Aird DZ, Dam LM, et al. Effective detection of toxigenic Clostridium difficile by a two-step algorithm including tests for antigen and cytotoxin. J Clin Microbiol. 2006;44:1145-1149.
5. Pepin J, Valiquette L, Alary ME, et al. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. CMAJ. 2004;171:466-472.
6. Pepin J, Valiquette L, Cossette B. Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec. CMAJ. 2005;173:1037-1042.
7. Severe Clostridium difficile-associated disease in populations previously at low risk: four states, 2005. MMWR Morb Mortal Wkly Rep. 2005;54:1201-1205.
8. McDonald LC, Killgore GE, Thompson A, et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med. 2005;353:2433-2441.
9. Reller ME, Lema CA, Perl TM, et al. Yield of stool culture with isolate toxin testing versus a two-step algorithm including stool toxin testing for detection of toxigenic Clostridium difficile. J Clin Microbiol. 2007;45:3601-3605.
10. Sloan LM, Duresko BJ, Gustafson DR, et al. Comparison of real-time PCR for detection of the tcdC gene with four toxin immunoassays and culture in diagnosis of Clostridium difficile infection. J Clin Microbiol. 2008;46:1996-2001.
11. Stamper PD, Alcabasa R, Aird D, et al. Comparison of a commercial real-time PCR assay for tcdB detection to a cell culture cytotoxicity assay and toxigenic culture for direct detection of toxin-producing Clostridium difficile in clinical samples. J Clin Microbiol. 2009;47:373-378.